vimarsana.com
Home
Live Updates
Press release Biocartis Group NV: Biocartis Announces Expans
Press release Biocartis Group NV: Biocartis Announces Expans
Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit -October 12, 2023 at 01:01 am EDT
PRESS RELEASE 12 October 2023, 7:00 CEST Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit Mechelen, Belgium, 12 October...
Related Keywords
United States ,
Mechelen ,
Region Flamande ,
Belgium ,
United Kingdom ,
America ,
Cian Kavanagh ,
Roger Moody ,
Degraders Serds ,
Assay Technologies Ltd ,
International Breast Cancer Study Group Trials ,
Neither The Company ,
Research Use Only ,
Company Or Biocartis ,
Exchange Commission ,
Biocartis Group ,
Announces Expansion ,
Chief Executive Officer ,
Cancer Subtyping Kit ,
Euronext Brussels ,
Polymerase Chain Reaction ,
United States Securities ,
Hazard Rates ,
Breast Cancer During ,
Results From ,
Clin Oncol ,
Resistant Breast Cancer ,
Breast Care ,
Selective Estrogen Receptor Degraders ,
Novel Breast Cancer Therapy ,
Intj Mol Sci ,
Semin Oncol ,
Circulating Tumor ,
Transl Oncol ,
Cancer Res ,
Markets ,